136282-40-1

Upstream product

• 136282-39-8 1,4-di-O-allyl-2,5,6-tri-O-benzyl-3-O-tert-butyldimethylsilyl-myo-inositol 
• 112204-04-3 3,6-di-O-allyl-1,2:4,5-di-O-cyclohexylidene-myo-inositol 
• 112204-05-4 (+/-)-3,6-di-O-allyl-1,2-O-cyclohexylidene-myo-inositol 
• 34361-60-9 1,2:4,5-dicyclohexylidene-myo-inositol 
• 87-89-8 D-myo-inositol 
• 98906-35-5 (+/-)-1,4-di-O-allyl-5,6-di-O-benzyl-myo-inositol 
• 112204-06-5 (+/-)-3,6-di-O-allyl-4,5-di-O-benzyl-1,2-O-cyclohexylidene-myo-inositol 
• 136282-38-7 1,4-di-O-allyl-5,6-di-O-benzyl-3-O-tert-butyldimethylsilyl-myo-inositol 

Downstream Products

• 136304-46-6 2,5,6-tri-O-benzyl-myo-inositol 3-(benzyl methylphosphonate) 
• 136282-41-2 Methyl-phosphonic acid benzyl ester (1R,2R,3R,4S,5S,6R)-2,4,5-tris-benzyloxy-3,6-bis-[((E)-propenyl)oxy]-cyclohexyl ester 

Relevant academic research and scientific papers

Synthesis of racemic 3-methylphosphonate analogues of myo-inositol 3,4-bis- and 1,3,4-trisphosphate

The partially benzyl protected myo-inositol derivatives 11a and 11b, the C-4 and C-1,4 hydroxyl function(s) of which are protected with temporary trans-prop-1-enyl protecting group(s), were readily converted into the respective title compounds 18a and 18b by sequential methylphosphonylation, mild cleavage of the trans-prop-1-enyl group(s), phosphorylation and removal of all permanent benzyl protecting groups.